National Influenza Vaccine Summit June 2006

The National Influenza Vaccine Summit convened a second meeting on Wednesday, June 22, 2006 at the Marriott O'Hare in Chicago.

Vaccine supplies are projected to be over 100 million doses for the 2006-2007 influenza vaccination season. This would be a record high for influenza vaccine production so the purpose of this meeting was to discuss, develop, and implement plans to enhance utilization of influenza vaccine for the 2006-2007 season.

The following materials were included in the package provided at the Summit meeting:

• The first Summit Newsletter (see above, PDF, 179KB)
• Influenza vaccine distribution Q and As (PDF, 141KB)
• Influenza vaccine target populations (PDF, 109KB)

• Executive summary of the June 22, 2006 meeting (PDF, 140KB)
• Slide presentation made by L.J Tan to the Academy for Educational Development's Technical assistance call on June 27, 2006. (PDF, 325KB)
• Final roster of participants at the June 2006 National Influenza Vaccine Summit meeting (Excel, 351KB)
• Final agenda (PDF, 71KB)

Presentations made at the June 2006 National Influenza Vaccine Summit meeting

General session

• Update on April 2006 Data Sharing Meeting - Jeanne Santoli (PDF, 105KB)       

Manufacturers' updates

• Sanofi Pasteur - Phil H. Hosbach (PDF, 259KB)
• Novartis vaccines - Ariyapadi Krishnaraj (PDF, 1MB)
• MedImmune - Mark C. Twyman (PDF, 1MB)
• GlaxoSmithKline - John C. Neal (PDF, 499KB)     

Session one

• Communication techniques to motivate the public - Glen Nowak (PDF, 256KB)
• Novel approaches to increase public utilization of influenza vaccine - Abigail Shefer (PDF, 232KB)
• Importance of vaccination of health care workers - Ray Strikas 
  Slides 1-6 (PDF, 2MB), Slides 7-12 (PDF, 2MB)
• American Lung Association's "Faces of Influenza" campaign - Todd Whitley (PDF, 2MB)

Session two

• Challenges facing health care providers in promoting influenza vaccine - William Schaffner(PDF, 539KB)
• Due to inclement weather, Dr. Poland was unable to make his presentation.

Short term teams established by the Summit at the June 2006 meeting

The Summit agreed at its June 22nd meeting to create six teams with the aggressive timeline of creating strategies/messages for the upcoming influenza season to enhance utilization of influenza vaccine. Teams are asked to think creatively to derive plans for the short-term goal of increasing utilization for this upcoming season. While long-term goals are also necessary and there will be some overlap between this current effort and future long-term planning efforts, the tight deadline compelled the teams to focus on the short-term goal.

Look to this Web site for updates on the products/ideas that have come from the teams and are currently being implemented.

Team one: Targeting health care workers. Co-Leads: American Medical Association (contact - L.J Tan) and the National Vaccine Program Office (contact - Ray Strikas). Industry Liaison: Henry Schein. Executive Committee Liaison: L.J Tan.

Please visit the Summit's HCW Web site

Team two: Targeting children aged 6 mos. through 18 years. Co-Leads: American Academy of Pediatrics (contact - Alison Siwek) and the Association of State and Territorial Health Officers (contact - Anna DeBlois). Industry Liaisons: MedImmune and sanofi pasteur. Executive Committee Liaison: Kathleen Coelingh.

Team 2 Report (describes the teams recommendations that are currently being implemented, PDF, 111KB)
Child Influenza Flash Card (explains risks of influenza and the role of school children in transmission, PDF, 398KB)
National Association of School Nurses Tips for parents (can be filled in by any school nurse and given to parents, PDF, 177KB)

Team three: All contacts of high-priority populations with an eye towards “Universal".  Co-Leads: Immunization Action Coalition (contacts - Deborah Wexler and Clem Lewin) Industry Liaisons: Novartis and GSK. Executive Committee Liaison: Deborah Wexler.

Team four: Extending the vaccination season. Lead: American Pharmacists Association (contact - Mitch Rothholz). Industry Liaison: GSK. Executive Committee Liaison: Mitch Rothholz.

Team five: Unifying/creating provider toolkit. Co-Leads: Colorado Department of Public Health and Environment (contact - Roberta Smith) and Rhode Island Department of Health (contact - AnneMarie Beardsworth) Industry Liaison: sanofi pasteur.  Executive Committee Liaison: Steve Wright.

Please visit the Summit's Resources for health care providers Web site

Team six: Utilizing partnerships to improve education, reduce barriers for immunizing, and sharing fiscal risk of influenza vaccine.  Lead: CDC/ISD (contacts - Lance Rodewald, and Jeanne Santoli). Executive Committee Liaison: Abby Shefer.